Cargando…
PGM5: a novel diagnostic and prognostic biomarker for liver cancer
BACKGROUND: Liver cancer is a common malignancy and a significant public health problem worldwide, but diagnosis and prognostic evaluation remain challenging for clinicians. Metabolic reprogramming is a hallmark of cancer, and we therefore examined the diagnostic and prognostic value of a metabolic...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568247/ https://www.ncbi.nlm.nih.gov/pubmed/31218127 http://dx.doi.org/10.7717/peerj.7070 |